AstraZeneca plc using EPIC/TICKER code (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OUTPERFORM’ today by analysts at Credit Suisse. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Credit Suisse have set a target price of 8200 GBX on its stock. This would imply the analyst believes there is now a potential upside of 10.3% from today’s opening price of 7437 GBX. Over the last 30 and 90 trading days the company share price has increased 54 points and increased 546 points respectively. The 52 week high for the share price is currently at 7646 GBX while the 52 week low for the share price is 5312 GBX.
AstraZeneca plc has a 50 day moving average of 7,325.85 GBX and a 200 day moving average of 6,778.02. There are currently 1,311,913,268 shares in issue with the average daily volume traded being 2,005,581. Market capitalisation for LON:AZN is £97,829,372,394 GBP.
